Nonetheless, a study of the remaining lifetime risk for the subset of women who were older than 65 years in the population-based CARRIERS project [36] indicated that BRCA1, BRCA2, and PALB2 PVs were associated with enough breast cancer risk to warrant high-risk screening [37]. Here, PALB2 is linked to breast carcinoma.